Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Psychiatry. 2007 Summer;70(2):167-74.

Pilot trial of memantine in the treatment of posttraumatic stress disorder.

Author information

  • 1VA Central California Health Care System Fresno, Fresno, CA 93703, USA. matthew.battista@med.va.gov

Abstract

This multiple case series was initially designed as a prospective, open-label, 12-week trial investigation evaluating memantine (Namenda) for the treatment of psychiatric and cognitive symptoms associated with PTSD. In a selected, small sample of individuals (n = 4) with combat PTSD, treatment with memantine produced consistent improvement on a delayed recall measure of memory, variable reduction of depressive symptoms, and variable reduction in hyperarousal symptoms. These data suggest potential positive treatment outcomes, both cognitively and psychiatrically, and provide rationale for future double-blind, placebo-controlled studies of memantine in PTSD.

PMID:
17661541
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Write to the Help Desk